These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9522040)

  • 1. Proteomics--a new way for drug target discovery.
    Müllner S; Neumann T; Lottspeich F
    Arzneimittelforschung; 1998 Jan; 48(1):93-5. PubMed ID: 9522040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
    Workman P
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinatorial compound libraries for drug discovery: an ongoing challenge.
    Geysen HM; Schoenen F; Wagner D; Wagner R
    Nat Rev Drug Discov; 2003 Mar; 2(3):222-30. PubMed ID: 12612648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transcriptomes for serial analysis of gene expression].
    Marti J; Piquemal D; Manchon L; Commes T
    J Soc Biol; 2002; 196(4):303-7. PubMed ID: 12645300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmaco-proteomic analysis: application of proteomic analysis to the discovery and development of new drugs].
    Chapal N; Laplanche M; Ribes G; Pau B; Garin J; Petit P
    J Soc Biol; 2002; 196(4):317-22. PubMed ID: 12645303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis, identification and correction of some errors of model refseqs appeared in NCBI Human Gene Database by in silico cloning and experimental verification of novel human genes].
    Zhang DL; Ji L; Li YD
    Yi Chuan Xue Bao; 2004 May; 31(5):431-43. PubMed ID: 15478601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery.
    Fischer HP
    Biotechnol Annu Rev; 2005; 11():1-68. PubMed ID: 16216773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of gene array technology and proteomics in the search of new targets of diseases for therapeutics.
    Ferrer-Alcón M; Arteta D; Guerrero MJ; Fernandez-Orth D; Simón L; Martinez A
    Toxicol Lett; 2009 Apr; 186(1):45-51. PubMed ID: 19022361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technology evaluation: SAGE, Genzyme molecular oncology.
    Bartlett J
    Curr Opin Mol Ther; 2001 Feb; 3(1):85-96. PubMed ID: 11249736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yeast genomics and proteomics in drug discovery and target validation.
    Parsons AB; Geyer R; Hughes TR; Boone C
    Prog Cell Cycle Res; 2003; 5():159-66. PubMed ID: 14593709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 7 TM G-protein-coupled receptor target family.
    Jacoby E; Bouhelal R; Gerspacher M; Seuwen K
    ChemMedChem; 2006 Aug; 1(8):761-82. PubMed ID: 16902930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges of drug discovery for personalized medicine.
    Jain KK
    Curr Opin Mol Ther; 2006 Dec; 8(6):487-92. PubMed ID: 17243483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How molecular profiling could revolutionize drug discovery.
    Stoughton RB; Friend SH
    Nat Rev Drug Discov; 2005 Apr; 4(4):345-50. PubMed ID: 15789121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel drug discovery and molecular biological methods, via DNA, RNA and protein changes using structure-function transitions: Transitional structural chemogenomics, transitional structural chemoproteomics and novel multi-stranded nucleic acid microarray.
    Gagna CE; Lambert WC
    Med Hypotheses; 2006; 67(5):1099-114. PubMed ID: 16828979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ATCG of drug discovery.
    Fernandes PB
    Curr Opin Mol Ther; 2000 Dec; 2(6):624-32. PubMed ID: 11249739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathway proteomics and chemical proteomics team up in drug discovery.
    Hopf C; Bantscheff M; Drewes G
    Neurodegener Dis; 2007; 4(2-3):270-80. PubMed ID: 17596721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Finding the target after screening the phenotype.
    Hart CP
    Drug Discov Today; 2005 Apr; 10(7):513-9. PubMed ID: 15809197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based approaches to antibiotic drug discovery.
    Nicola G; Abagyan R
    Curr Protoc Microbiol; 2009 Feb; Chapter 17():Unit17.2. PubMed ID: 19235149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications of biotechnology to pharmacology and toxicology.
    Guillouzo A
    Cell Mol Biol (Noisy-le-grand); 2001 Dec; 47(8):1301-8. PubMed ID: 11838950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.